Group calls for agency to boost UK bioscience industryBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7425.1183 (Published 20 November 2003) Cite this as: BMJ 2003;327:1183
- Mark Gould
A government backed working group has this week called for the creation of a national body to coordinate “mutually advantageous” partnerships between the NHS and the bioscience industry, which would speed the development of new treatments and generate income for patient care.
The Bioscience Innovation and Growth Team (BIGT) says a national clinical trials agency would be at the centre of a raft of financial and regulatory changes to ensure that UK bioscience can compete with the United …
Log in using your username and password
Log in through your institution
Sign up for a free trial